ImVitro is a deeptech start-up on a mission to change how embryos are selected in IVF using computer vision and AI, combined with real-world patient data.

First Year of Investment 2022
Type of Investment Early Stage
Investment Status Current
Investment Lead Charlotte Barttelot

Infertility affects millions of people of reproductive age worldwide. According to the NHS, 1 in 7 couples may have difficulty conceiving. In the United States, 10% to 15% of couples are infertile. As a result, people turn to assisted reproductive technology (ART) or in-vitro fertilization (IVF).

Imvitro's B2B SaaS platform applies computer vision and artificial intelligence to the IVF fertility imaging process. Their vision is to create an easier path to parenthood by ensuring quality control along the entire IVF workflow and personalising all medical decisions to maximize success rates.

Newsletter Sign Up

Sign up for latest news